Dalmane

Buy Dalmane (Flurazepam) – Medical Information Overview (EU Context)

Product Overview

Dalmane is a prescription-only benzodiazepine hypnotic containing the active substance flurazepam. It is used for the short-term treatment of severe insomnia, particularly when sleep maintenance is significantly disturbed.

Flurazepam acts on the central nervous system by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces neuronal excitability. This produces sedative, hypnotic (sleep-inducing), anxiolytic, muscle-relaxant, and anticonvulsant effects.

In European clinical practice, flurazepam is strictly controlled and generally reserved for short-term use due to its long half-life and risk of next-day sedation.

Clinical Uses

Dalmane (flurazepam) may be used for:

• Short-term treatment of severe insomnia
• Difficulty maintaining sleep (sleep maintenance insomnia)
• Short-duration sleep disturbances requiring pharmacological intervention

It is not intended for long-term management of chronic insomnia.

Mechanism of Action

Flurazepam enhances GABA-A receptor activity in the brain, leading to:

• Reduced neuronal excitability
• Sleep induction and improved sleep maintenance
• Sedation and calming effects
• Muscle relaxation

Due to its long-acting active metabolites, effects may persist into the following day.

Safety Information and Warnings

Dalmane must only be used under medical supervision.

Common risks and side effects include:

• Daytime drowsiness and “hangover” sedation
• Dizziness and impaired coordination
• Confusion, especially in elderly patients
• Memory impairment
• Reduced reaction time
• Increased risk of falls and accidents

Risk of severe sedation increases when combined with alcohol, opioids, or other CNS depressants.

Patients should not drive or operate machinery if affected the next day.

Dependence, Tolerance, and Withdrawal

Flurazepam carries a risk of:

• Physical dependence
• Psychological dependence
• Tolerance with repeated use

Abrupt discontinuation may lead to withdrawal symptoms such as:

• Rebound insomnia
• Anxiety and irritability
• Tremors
• Restlessness
• In severe cases, seizures

Use should be limited in duration and discontinued gradually under medical supervision.

Drug Interactions

Dalmane may interact with:

• Alcohol (increased risk of severe sedation and respiratory depression)
• Opioids (additive CNS depression, risk of respiratory failure)
• Other benzodiazepines or sedative-hypnotics
• Antidepressants, antipsychotics, and antihistamines
• CYP450 inhibitors that may increase benzodiazepine levels

A full medication review is required before use.

Contraindications and Precautions

Flurazepam is not suitable for:

• Severe respiratory insufficiency without monitoring
• Sleep apnea syndrome without supervision
• Severe hepatic impairment
• Known hypersensitivity to benzodiazepines
• Long-term continuous use

Extra caution is required in elderly patients due to prolonged sedation and fall risk.

Special Populations

• Elderly patients: increased risk of confusion, sedation, and falls
• Pregnancy: use only if clearly necessary under medical supervision
• Breastfeeding: may pass into breast milk and affect the infant

Regulatory Note (EU Context)

Flurazepam (Dalmane) is a controlled prescription hypnotic in Europe. Its use is limited to short-term treatment of severe insomnia due to risks of dependence, residual sedation, and impaired psychomotor function.

Conclusion

Dalmane (flurazepam) is a long-acting benzodiazepine hypnotic used for short-term treatment of severe insomnia. It enhances GABA activity in the brain, producing sedative and sleep-promoting effects. Due to risks of next-day impairment, dependence, and withdrawal, it must only be used under strict medical supervision.